I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Clinical validation of circulating GDF15/MIC-1 as a marker ..:
Mahon, KL
;
Sutherland, SI
;
Lin, HM
...
Prostate, 2024, 84 (8), pp. 747 - 755. , 2024
Link:
https://repository.icr.ac.uk/handle/internal/6269
RT Journal T1
Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancer
UL https://suche.suub.uni-bremen.de/peid=base-ftinstcancerres:oai:repository.icr.ac.uk:internal_6269&Exemplar=1&LAN=DE A1 Mahon, KL A1 Sutherland, SI A1 Lin, HM A1 Stockler, MR A1 Gurney, H A1 Mallesara, G A1 Briscoe, K A1 Marx, G A1 Higano, CS A1 de Bono, JS A1 Chi, KN A1 Clark, G A1 Breit, SN A1 Brown, DA A1 Horvath, LG PB WILEY YR 2024 K1 Science & Technology K1 Life Sciences & Biomedicine K1 Endocrinology & Metabolism K1 Urology & Nephrology K1 biomarker K1 docetaxel K1 growth differentiation factor 15 K1 metastatic castration-resistant prostate cancer K1 prognosis K1 therapeutic response K1 MACROPHAGE INHIBITORY CYTOKINE-1 K1 PHASE-III TRIAL K1 PLUS PREDNISONE K1 DOUBLE-BLIND K1 OPEN-LABEL K1 PLACEBO K1 GROWTH K1 CHEMOTHERAPY K1 MITOXANTRONE K1 MULTICENTER JF Prostate, 2024, 84 (8), pp. 747 - 755 LK http://dx.doi.org/https://repository.icr.ac.uk/handle/internal/6269 DO https://repository.icr.ac.uk/handle/internal/6269 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)